Matches in Wikidata for { <http://www.wikidata.org/entity/Q64638244> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64638244 description "clinical trial" @default.
- Q64638244 description "ensayu clínicu" @default.
- Q64638244 description "klinisch onderzoek" @default.
- Q64638244 description "клінічне випробування" @default.
- Q64638244 name "Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer" @default.
- Q64638244 type Item @default.
- Q64638244 label "Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer" @default.
- Q64638244 prefLabel "Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer" @default.
- Q64638244 P1132 Q64638244-2EF52542-6479-4992-8FAC-C0A7CCBB5C04 @default.
- Q64638244 P1476 Q64638244-50292EFB-1F14-4149-8F2D-2FCB85484D00 @default.
- Q64638244 P17 Q64638244-2DDAA71F-7A73-427C-A70A-BFD399E47A33 @default.
- Q64638244 P17 Q64638244-51408E2A-C696-4746-881F-22DFCB99164B @default.
- Q64638244 P17 Q64638244-6AE6F776-4751-43F8-B5E6-855F902E03CE @default.
- Q64638244 P17 Q64638244-B016BD86-02F6-46E0-AD33-790557CAD13B @default.
- Q64638244 P17 Q64638244-DCD7F70C-123F-471D-B6D6-E07F52C297F4 @default.
- Q64638244 P1813 Q64638244-5995F5ED-0EFC-4833-A90C-2D96B77530E7 @default.
- Q64638244 P2899 Q64638244-0E2DA03B-616D-4A42-AE75-3A2B2FBABA17 @default.
- Q64638244 P3098 Q64638244-F59303BB-B0C2-4364-9FB9-652E00ACD555 @default.
- Q64638244 P31 Q64638244-3C2216E5-FAD9-469B-B34F-E1696A85798B @default.
- Q64638244 P580 Q64638244-2CB6B1F4-8814-4CCB-8DC4-6C09AA81181C @default.
- Q64638244 P582 Q64638244-1F1C1076-12CC-4029-97FC-F0CD85AB9A71 @default.
- Q64638244 P6099 Q64638244-10D5E70E-DD04-4727-BD87-AFC9C34F31BC @default.
- Q64638244 P8363 Q64638244-8AAF5027-3470-47A4-8B1A-E6097B69B695 @default.
- Q64638244 P1132 "+126" @default.
- Q64638244 P1476 "A Phase III Single Arm Study to Evaluate the Efficacy, Safety and Local Tolerability of a Subcutaneous 3-month Formulation of Triptorelin Pamoate (11.25 mg) in Patients With Locally Advanced or Metastatic Prostate Cancer" @default.
- Q64638244 P17 Q142 @default.
- Q64638244 P17 Q211 @default.
- Q64638244 P17 Q218 @default.
- Q64638244 P17 Q219 @default.
- Q64638244 P17 Q36 @default.
- Q64638244 P1813 "DKP 3M SC" @default.
- Q64638244 P2899 "+18" @default.
- Q64638244 P3098 "NCT01715129" @default.
- Q64638244 P31 Q30612 @default.
- Q64638244 P580 "2013-01-01T00:00:00Z" @default.
- Q64638244 P582 "2013-10-01T00:00:00Z" @default.
- Q64638244 P6099 Q42824827 @default.
- Q64638244 P8363 Q78089383 @default.